Accelmed

Accelmed operates as a specialized private equity firm, acquiring and investing in commercial-stage U.S. HealthTech companies. It also manages a venture capital division supporting emerging health technology startups developing medical devices, diagnostics, and therapeutics. Their investment strategy spans early-stage companies nearing regulatory approval and established businesses with existing commercial operations.

The firm was founded in 2009 by Uri Geiger, with initial backing from Israeli healthcare entrepreneur Mori Arkin. Accelmed began as a venture capital entity, identifying an opportunity to foster innovation across medical technology. This foundation evolved into a dedicated private equity strategy, aiming to acquire and scale established HealthTech businesses alongside early-stage investments.

Accelmed serves a diverse range of health technology companies, from nascent startups seeking growth capital to mature enterprises pursuing expansion. The firm’s vision is to advance healthcare innovation by providing financial backing and strategic insight to companies developing vital medical solutions. They strive to accelerate market penetration, ultimately enhancing patient care and global healthcare delivery.